Skip to main content

Post-IPO Equity Therapeutics Companies

Explore 204 therapeutics startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
204
Total Funding
$2.5B
Avg Funding
$100.6M
Cities
19

Export 204 Post-IPO Equity Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Rockville, United States
$185.0M
raised

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$75.0M
raised

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stamford, United States
$275.0M
raised

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$287.5M
raised

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Jan 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$11.2M
raised

Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
La Jolla, United States
$350.0M
raised

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oslo, Norway
$13.1M
raised

EXACT Therapeutics is a clinical stage biotech firm developing a technology platform for therapeutic enhancement Acoustic Cluster Therapy.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$250K
raised

Better Therapeutics develops prescription software for treating cardiometabolic diseases.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$30.0M
raised

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlton South, Australia
$2.9M
raised

Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$14.4M
raised

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$20.1M
raised

IN8Bio is a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$90.0M
raised

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$30.0M
raised

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$224K
raised

RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Richmond, United States
$115.0M
raised

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$99.2M
raised

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$18.0M
raised

Tivic Health is a commercial health tech company that develops bioelectronic medicine to alleviate symptoms of inflammatory conditions.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$60.0M
raised

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$602.0M
raised

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Tórtola, Spain
$1.3M
raised

CRISM Therapeutics is a pharmaceutical company that develops ChemoSeed to improve the clinical performance of cancer treatments.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$175.0M
raised

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Chester, United Kingdom
$55.0M
raised

Canton Strategic Holdings drives institutional blockchain adoption via the Canton Network, digital assets, and market digitization.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Halifax, Canada
$532K
raised

Appili Therapeutics is an anti-infective pharmaceutical development company.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Garden City, United States
$5.0M
raised

Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 151 to 175 of 204 companies

Ready to Connect with Post-IPO Equity Therapeutics Startups?

Get verified founder emails, funding details, and company data for 204 post-ipo equity therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked